Genomic therapy matching associated with improved survival when supported by clinical trial evidence
Matching cancer therapies to tumour genomic alterations was associated with longer survival in patients with…
Author Rachael Babin
Rachael Babin
Rachael Babin is a medical writer, communications expert, digital content producer and trained media host. Rachael co-founded The Oncology Network in 2014. She is Editor-in-Chief of Oncology News Australia, Publisher of The Oncology Newsletter and Host and Creator of The Oncology Podcast. Before creating The Oncology Network, Rachael worked for MOGA, COSA and an international academic publishing house.
Human–AI collaboration improves accuracy of oncology clinical trial pre-screening
A new study published in Nature Communications suggests that combining artificial intelligence with clinician review…
Adjuvant aumolertinib significantly improves disease-free survival after resection of EGFR-mutant NSCLC
New data from the phase III ARTS trial published in The Lancet Oncology confirm that…
Zanubrutinib demonstrates durable efficacy in CLL/SLL with del(17p) and/or TP53 mutations
Patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who carry deletion 17p…
Tech-enabled (p)rehabilitation shows promise in enhancing cancer surgery recovery
Early evidence suggests digital health tools may help improve recovery and patient-reported outcomes after major…
Triple-targeted therapy shows unprecedented efficacy in early pancreatic cancer models
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest common cancers, with historically limited therapeutic…
Cost-effectiveness of adjuvant immunotherapy varies by cancer type: new systematic review
As immunotherapy moves earlier into cancer treatment pathways, its clinical benefits are increasingly well established.…
Five-year survival benchmark for camrelizumab plus chemotherapy in RM-NPC
Recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) is a distinct head and neck malignancy strongly linked…
Growing numbers of people living with metastatic breast cancer: a population-based study from Australia
Advances in breast cancer treatment over recent decades have transformed outcomes for many patients. Earlier…
Low-dose aspirin does not reduce cancer incidence and may increase cancer-related mortality in older adults
New data published in JAMA Oncology from extended follow-up of the ASPREE and ASPREE-XT studies…